UroGen’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

UroGen develops and commercializes novel therapies for the treatment of uro-oncology diseases. Read more

UroGen develops and commercializes novel therapies for the treatment of uro-oncology diseases. Read more

Elizabeth Barrett's photo - President & CEO of UroGen

President & CEO

Elizabeth Barrett

CEO Approval Rating

52/100

Founded:

2004

Status:

PublicNASDAQURGN

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Urovant Sciences is a top competitor of UroGen. Urovant Sciences is a Public company that was founded in 2016 in Irvine, California. Urovant Sciences operates in the Biotechnology industry. Compared to UroGen, Urovant Sciences has 71 fewer employees.

Kymera is seen as one of UroGen's biggest rivals. Kymera was founded in 2016, and is headquartered in Watertown, Massachusetts. Kymera operates in the Biotechnology industry. Kymera generates $2.6M more revenue vs. UroGen.

Roivant is seen as one of UroGen's top competitors. Roivant was founded in New York, New York} in 2014. Roivant competes in the Pharmaceuticals industry. Compared to UroGen, Roivant generates $5.6M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is NexImmune a competitor of UroGen?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

UroGen's revenue is the ranked 32th among it's top 10 competitors. The top 10 competitors average 434.6M. Over the last one quarters, UroGen's revenue has decreased by 0%. Specifically, in Q2 2020's revenue was $ < 1M.

Acquisitions

No recent acquisitions found related to UroGen

UroGen Funding History

$58.2M

Since UroGen was founded in 2004, it has participated in 1 round of funding. In total UroGen has raised $58.2M. UroGen's funding round was on May 2017 for a total of $58.2M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
May 2017
$58.2M
-

Total Funding: $58.2M

Since UroGen was founded in 2004, it has participated in 1 round of funding. In total UroGen has raised $58.2M. UroGen's funding round was on May 2017 for a total of $58.2M

Investments

No recent investments found related to UroGen

UroGen News

September 10, 2020Zolmax News

$3.21 Million in Sales Expected for Urogen Pharma Ltd (NASDAQ:URGN) This Quarter

Equities research analysts expect that Urogen Pharma Ltd (NASDAQ:URGN) will announce sales of $3.21 m... See more »
September 9, 2020Philadelphia Citybizlist

UroGen Pharma Expands Executive Team

September 4, 2020MarketScreener

Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(marketscreener.com) UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solut... See more »
August 27, 2020FinanzNachrichten

Phase 2 APOLLO Clinical Trial Did Not Meet Primary Endpoint

WASHINGTON (dpa-AFX) - Biopharmaceutical company UroGen Pharma Ltd. (URGN) said Thursday that the Pha... See more »
August 19, 2020Zolmax News

Urogen Pharma Ltd (NASDAQ:URGN) Expected to Announce Quarterly Sales of $3.21 Million

Wall Street analysts predict that Urogen Pharma Ltd (NASDAQ:URGN) will post sales of $3.21 million fo... See more »

UroGen Press Releases

Headquarters

400 Alexander Park Drive 4th Floor

Princeton, New Jersey08540

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

UroGen develops and commercializes novel therapies for the treatment of uro-oncology diseases. UroGen was founded in 2004. UroGen's headquarters is located in Princeton, New Jersey, USA 08540. It has raised 58.2M in 1 round. The latest round was in Ma...

CEO

UroGen's President & CEO, Elizabeth Barrett, currently has an approval rating of 52%. UroGen's primary competitors are Urovant Sciences, Kymera & Roivant.

Website

urogen.com

Frequently Asked Questions about UroGen

  1. When was UroGen founded?

    UroGen was founded in 2004
  2. Who is UroGen's CEO?

    UroGen's CEO is Elizabeth Barrett
  3. How much revenue does UroGen generate?

    UroGen generates $ < 1M in revenue
  4. How much funding does UroGen have?

    UroGen has historically raised $58.2M in funding
  1. Where is UroGen's headquarters?

    UroGen's headquarters is in Princeton New Jersey, USA
  2. How many employees does UroGen have?

    UroGen has 78 employees
  3. What sector does UroGen operate in?

    UroGen is in Medical Research & Laboratories
  4. Who are UroGen's competitors?

    UroGen's top competitors are Urovant Sciences, Kymera, Roivant